Cite
MLA Citation
Huji Xu et al.. “IBI303, a biosimilar to adalimumab, for the treatment of patients with ankylosing spondylitis in China: a randomised, double-blind, phase 3 equivalence trial.” Lancet, vol. 1, 2019, pp. e35–e43. http://access.bl.uk/ark:/81055/vdc_100101585387.0x000001